2021 Q4 Form 10-K Financial Statement

#000090831122000036 Filed on March 16, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $25.13M $24.25M $22.67M
YoY Change 40.92% 39.89% 37.33%
Cost Of Revenue $15.32M $12.81M $12.26M
YoY Change 25.66% 0.45% 6.81%
Gross Profit $9.807M $11.44M $10.41M
YoY Change 73.88% 149.26% 106.98%
Gross Profit Margin 39.03% 47.18% 45.92%
Selling, General & Admin $1.594M $1.625M $1.146M
YoY Change -2.21% -6.61% -31.38%
% of Gross Profit 16.25% 14.2% 11.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.977M $5.116M $5.075M
YoY Change -7.15% -2.92% -2.4%
% of Gross Profit 50.75% 44.72% 48.75%
Operating Expenses $6.539M $6.686M $6.215M
YoY Change -10.55% -4.62% -9.53%
Operating Profit $3.268M $4.755M $4.196M
YoY Change -295.69% -296.49% -328.04%
Interest Expense -$1.923M $2.185M $2.673M
YoY Change -29.04% -17.33% -7.7%
% of Operating Profit -58.84% 45.95% 63.7%
Other Income/Expense, Net
YoY Change
Pretax Income $1.345M $2.570M $1.523M
YoY Change -130.71% -148.06% -132.19%
Income Tax $676.0K $946.0K $996.0K
% Of Pretax Income 50.26% 36.81% 65.4%
Net Earnings $666.0K $1.624M $530.0K
YoY Change -115.17% -130.51% -113.11%
Net Earnings / Revenue 2.65% 6.7% 2.34%
Basic Earnings Per Share -$0.14 -$0.28
Diluted Earnings Per Share $28.47K -$0.14 -$0.28
COMMON SHARES
Basic Shares Outstanding 23.37M shares 23.35M shares 15.10M shares
Diluted Shares Outstanding 23.35M shares 15.10M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.31M $14.55M $59.73M
YoY Change -33.6% -54.67% -20.57%
Cash & Equivalents $22.31M $14.55M $59.73M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $3.396M $2.569M $1.795M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $25.71M $17.12M $61.53M
YoY Change -27.18% -49.2% -20.92%
LONG-TERM ASSETS
Property, Plant & Equipment $498.0M $498.9M $498.5M
YoY Change -1.58% -1.08% -1.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $47.44M $47.35M $46.14M
YoY Change 3.12% 4.75% -2.03%
Total Long-Term Assets $635.2M $657.9M $643.3M
YoY Change -2.33% 0.53% -0.79%
TOTAL ASSETS
Total Short-Term Assets $25.71M $17.12M $61.53M
Total Long-Term Assets $635.2M $657.9M $643.3M
Total Assets $660.9M $675.0M $704.8M
YoY Change -3.61% -1.9% -2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.75M $17.03M $13.68M
YoY Change 31.78% 19.91% 4.41%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.29M $26.45M $24.31M
YoY Change 15.9% 18.61% 15.21%
LONG-TERM LIABILITIES
Long-Term Debt $201.1M $222.2M $260.7M
YoY Change -37.98% -31.94% -29.86%
Other Long-Term Liabilities $17.10M $15.23M $12.80M
YoY Change 66.0% 53.81% 37.65%
Total Long-Term Liabilities $218.2M $237.4M $273.5M
YoY Change -34.77% -29.42% -28.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.29M $26.45M $24.31M
Total Long-Term Liabilities $218.2M $237.4M $273.5M
Total Liabilities $249.5M $263.9M $297.8M
YoY Change -31.0% -26.44% -25.93%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $24.00K $24.00K $24.00K
YoY Change 60.0% 60.0% 60.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $373.2M $375.2M $364.2M
YoY Change
Total Liabilities & Shareholders Equity $660.9M $675.0M $704.8M
YoY Change -3.61% -1.9% -2.95%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income $666.0K $1.624M $530.0K
YoY Change -115.17% -130.51% -113.11%
Depreciation, Depletion And Amortization $4.977M $5.116M $5.075M
YoY Change -7.15% -2.92% -2.4%
Cash From Operating Activities $32.39M -$3.946M $13.21M
YoY Change 472.21% -304.46% -1885.14%
INVESTING ACTIVITIES
Capital Expenditures -$2.266M -$3.891M -$453.0K
YoY Change -70.38% 6.31% -88.44%
Acquisitions
YoY Change
Other Investing Activities -$4.706M $2.990M -$819.0K
YoY Change -485.74% -161.27% -94.23%
Cash From Investing Activities -$6.972M -$901.0K -$1.262M
YoY Change 8.43% -89.46% -93.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.91M -38.54M 13.10M
YoY Change -837.0% 2.67% -81.76%
NET CHANGE
Cash From Operating Activities 32.39M -3.946M 13.21M
Cash From Investing Activities -6.972M -901.0K -1.262M
Cash From Financing Activities -17.91M -38.54M 13.10M
Net Change In Cash 7.506M -43.39M 25.05M
YoY Change 352.17% -1.75% -52.72%
FREE CASH FLOW
Cash From Operating Activities $32.39M -$3.946M $13.21M
Capital Expenditures -$2.266M -$3.891M -$453.0K
Free Cash Flow $34.65M -$55.00K $13.66M
YoY Change 160.35% -100.98% 329.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000908311
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/srt/2021-01-31#HotelMember
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
506040000 USD
CY2021 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/srt/2021-01-31#HotelMember
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.3333
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
1-13610
CY2021 dei Entity Registrant Name
EntityRegistrantName
CREATIVE MEDIA & COMMUNITY TRUST CORPORATION
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-6446078
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
17950 Preston Road,
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600,
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas,
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75252
CY2021 dei City Area Code
CityAreaCode
(972)
CY2021 dei Local Phone Number
LocalPhoneNumber
349-3200
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
126100000 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23369331 shares
CY2021 dei Auditor Firm
AuditorFirmId
34
CY2021 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2021 dei Auditor Location
AuditorLocation
Los Angeles, CA
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
497984000 USD
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
3396000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22311000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33636000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11340000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10013000 USD
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
73543000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
83135000 USD
CY2020Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1737000 USD
CY2021Q4 cmct Deferred Rent Receivable And Charges Net
DeferredRentReceivableAndChargesNet
36095000 USD
CY2020Q4 cmct Deferred Rent Receivable And Charges Net
DeferredRentReceivableAndChargesNet
35956000 USD
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5251000 USD
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6313000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
10946000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
8787000 USD
CY2021Q4 us-gaap Assets
Assets
660866000 USD
CY2020Q4 us-gaap Assets
Assets
685617000 USD
CY2021Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
201145000 USD
CY2020Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
324313000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26751000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
20327000 USD
CY2021Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
237000 USD
CY2020Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
587000 USD
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
4541000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
6706000 USD
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
16861000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
9733000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
249535000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
361666000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23369331 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23369331 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14827410 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14827410 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
24000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
866746000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
794127000 USD
CY2021Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
804227000 USD
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
778519000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
373204000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
277659000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
345000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
455000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
373549000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
278114000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
660866000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
685617000 USD
CY2021 cmct Operating Lease And Other Property Revenue
OperatingLeaseAndOtherPropertyRevenue
52838000 USD
CY2020 cmct Operating Lease And Other Property Revenue
OperatingLeaseAndOtherPropertyRevenue
54823000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16722000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11882000 USD
CY2021 cmct Interest And Other Operating Income
InterestAndOtherOperatingIncome
21366000 USD
CY2020 cmct Interest And Other Operating Income
InterestAndOtherOperatingIncome
10503000 USD
CY2021 us-gaap Revenues
Revenues
90926000 USD
CY2020 us-gaap Revenues
Revenues
77208000 USD
CY2021 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
39272000 USD
CY2020 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
37544000 USD
CY2021 cmct Related Party Asset Management Fees And Other Fees
RelatedPartyAssetManagementFeesAndOtherFees
9030000 USD
CY2020 cmct Related Party Asset Management Fees And Other Fees
RelatedPartyAssetManagementFeesAndOtherFees
9793000 USD
CY2021 us-gaap Interest Expense
InterestExpense
9413000 USD
CY2020 us-gaap Interest Expense
InterestExpense
11415000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6844000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6772000 USD
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
143000 USD
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20112000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21406000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-281000 USD
CY2021 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
88785000 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
92945000 USD
CY2021 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2141000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15737000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2992000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-722000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-851000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-15015000 USD
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000 USD
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-850000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-15016000 USD
CY2021 cmct Redeemable Preferred Stock Dividends Declared And Accumulated
RedeemablePreferredStockDividendsDeclaredAndAccumulated
18763000 USD
CY2020 cmct Redeemable Preferred Stock Dividends Declared And Accumulated
RedeemablePreferredStockDividendsDeclaredAndAccumulated
18002000 USD
CY2021 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
253000 USD
CY2020 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
377000 USD
CY2021 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
113000 USD
CY2020 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
72000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19979000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33467000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19187000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14748000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19187000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14748000 shares
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
278195000 USD
CY2020 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
51000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
222000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2359000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
28000 USD
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.300
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
4431000 USD
CY2020 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
1.560
CY2020 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
35483000 USD
CY2020 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
377000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-15015000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
278114000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
278114000 USD
CY2021 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
9000 USD
CY2021 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
118000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
220000 USD
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.300
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
5732000 USD
CY2021 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
1.560
CY2021 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
45806000 USD
CY2021 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
253000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
76921000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-851000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
373549000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-851000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-15015000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20188000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21085000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-281000 USD
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1068000 USD
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1192000 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-61000 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-84000 USD
CY2021 cmct Unrealized Premium Adjustment
UnrealizedPremiumAdjustment
2930000 USD
CY2020 cmct Unrealized Premium Adjustment
UnrealizedPremiumAdjustment
1281000 USD
CY2021 cmct Amortization And Accretion On Loans Receivable Net
AmortizationAndAccretionOnLoansReceivableNet
622000 USD
CY2020 cmct Amortization And Accretion On Loans Receivable Net
AmortizationAndAccretionOnLoansReceivableNet
410000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-82000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2622000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-995000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
220000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
222000 USD
CY2021 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
96991000 USD
CY2020 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
28131000 USD
CY2021 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
109000000 USD
CY2020 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
25722000 USD
CY2021 us-gaap Proceeds From Collection Of Loans Held For Sale
ProceedsFromCollectionOfLoansHeldForSale
1786000 USD
CY2020 us-gaap Proceeds From Collection Of Loans Held For Sale
ProceedsFromCollectionOfLoansHeldForSale
3695000 USD
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2559000 USD
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-935000 USD
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1519000 USD
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
419000 USD
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1340000 USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1233000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2574000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1080000 USD
CY2021 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1669000 USD
CY2020 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1838000 USD
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7128000 USD
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-274000 USD
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
7009000 USD
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
4675000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46281000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12827000 USD
CY2021 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
4047000 USD
CY2020 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
14731000 USD
CY2021 cmct Payments To Acquire Real Estate And Mortgage Note Receivable
PaymentsToAcquireRealEstateAndMortgageNoteReceivable
2933000 USD
CY2020 cmct Payments To Acquire Real Estate And Mortgage Note Receivable
PaymentsToAcquireRealEstateAndMortgageNoteReceivable
6131000 USD
CY2021 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
36299000 USD
CY2020 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
25393000 USD
CY2021 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
30584000 USD
CY2020 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
7884000 USD
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-51000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12695000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38320000 USD
CY2021 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
157910000 USD
CY2020 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
57584000 USD
CY2021 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
35396000 USD
CY2020 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
77516000 USD
CY2021 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1786000 USD
CY2020 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3695000 USD
CY2021 cmct Payments Of Deferred Stock Issuance Costs
PaymentsOfDeferredStockIssuanceCosts
1149000 USD
CY2020 cmct Payments Of Deferred Stock Issuance Costs
PaymentsOfDeferredStockIssuanceCosts
943000 USD
CY2021 cmct Paymentof Other Deferred Costs
PaymentofOtherDeferredCosts
1000 USD
CY2020 cmct Paymentof Other Deferred Costs
PaymentofOtherDeferredCosts
983000 USD
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3979000 USD
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4431000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
78825000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1900000 USD
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2020 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
28000 USD
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
29829000 USD
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
41958000 USD
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
18045000 USD
CY2020 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
16536000 USD
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
2755000 USD
CY2020 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
2084000 USD
CY2021 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
118000 USD
CY2020 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
51000 USD
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
9000 USD
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7702000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43649000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35947000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43584000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33195000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9998000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33651000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43649000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22311000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33636000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11340000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10013000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33651000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43649000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
8463000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
10315000 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
2900000 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
273000 USD
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2127000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
267000 USD
CY2021 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2020 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
125000 USD
CY2021 cmct Stock Offering Costs Not Yet Paid
StockOfferingCostsNotYetPaid
161000 USD
CY2020 cmct Stock Offering Costs Not Yet Paid
StockOfferingCostsNotYetPaid
675000 USD
CY2021 cmct Accrual Of Dividends Payable To Preferred Stockholders
AccrualOfDividendsPayableToPreferredStockholders
12051000 USD
CY2020 cmct Accrual Of Dividends Payable To Preferred Stockholders
AccrualOfDividendsPayableToPreferredStockholders
11343000 USD
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1753000 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2021 cmct Offering Costs Offset Against Redeemable Preferred Stock Temporary Equity
OfferingCostsOffsetAgainstRedeemablePreferredStockTemporaryEquity
400000 USD
CY2020 cmct Offering Costs Offset Against Redeemable Preferred Stock Temporary Equity
OfferingCostsOffsetAgainstRedeemablePreferredStockTemporaryEquity
583000 USD
CY2021 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
45806000 USD
CY2020 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
35483000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
174000 USD
CY2020 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
377000 USD
CY2021 cmct Redeemable Preferred Stock Fees Incurred But Not Yet Paid
RedeemablePreferredStockFeesIncurredButNotYetPaid
638000 USD
CY2021 cmct Reclassifications Of Permanent Equity To Liabilities
ReclassificationsOfPermanentEquityToLiabilities
48000 USD
CY2020 cmct Reclassifications Of Permanent Equity To Liabilities
ReclassificationsOfPermanentEquityToLiabilities
25000 USD
CY2021 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
253000 USD
CY2020 cmct Redeemable Preferred Stock Fees Incurred But Not Yet Paid
RedeemablePreferredStockFeesIncurredButNotYetPaid
493000 USD
CY2021 us-gaap Stock Issued1
StockIssued1
9174000 USD
CY2020 us-gaap Stock Issued1
StockIssued1
7400000 USD
CY2021 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. ORGANIZATION AND OPERATIONS</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Creative Media &amp; Community Trust Corporation (formerly known as CIM Commercial Trust Corporation) (the “Company”), is a Maryland corporation and real estate investment trust (“REIT”). The Company’s portfolio of investments currently consists of Class A and creative office real assets in vibrant and improving metropolitan communities throughout the United States. The Company seeks to acquire, operate and develop premier multifamily and creative office assets that cater to rapidly growing industries such as technology, media and entertainment in vibrant and emerging communities throughout the United States. The Company seeks to apply the expertise of CIM Group, L.P. (“CIM Group”) to the acquisition, development and operation of top-tier multifamily properties situated in dynamic markets with similar business and employment characteristics to its creative office investments. The Company was originally organized in 1993 as PMC Commercial Trust (“PMC Commercial”), a Texas real estate investment trust.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s common stock, $0.001 par value per share (“Common Stock”), is currently traded on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CMCT”, and on the Tel Aviv Stock Exchange (the “TASE”) under the ticker symbol “CMCT-L.” The Company’s Series L preferred stock, $0.001 par value per share (“Series L Preferred Stock”), is currently traded on Nasdaq and on the TASE, in each case under the ticker symbol “CMCTP.” The Company has authorized for issuance 900,000,000 shares of common stock and 100,000,000 shares of preferred stock (“Preferred Stock”).</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed Articles of Amendment (the “Reverse Stock Split Amendment”) to effectuate a one-for-three reverse stock split of the Company’s Common Stock, effective on September 3, 2019 (the “Reverse Stock Split”). Pursuant to the Reverse Stock Split Amendment, every three shares of Common Stock issued and outstanding immediately prior to the effective time of the Reverse Stock Split were converted into one share of Common Stock, par value $0.003 per share. In connection with the Reverse Split Amendment, the Company filed Articles of Amendment to revert the par value of the Common Stock issued and outstanding from $0.003 per share to $0.001 per share, effective as of September 3, 2019, following the effective time of the Reverse Split Amendment. All Common Stock and per share of Common Stock amounts set forth in this Annual Report on Form 10-K have been adjusted to give retroactive effect to the Reverse Stock Split, unless otherwise stated.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted a continuous public offering of Series A Preferred Units from October 2016 through January 2020, where each Series A Preferred Unit consisted of one share of Series A Preferred Stock, par value $0.001 per share, of the Company (collectively, the “Series A Preferred Stock”) with an initial stated value of $25.00 per share, subject to adjustment (the “Series A Preferred Stock Stated Value”), and one warrant (collectively, the “Series A Preferred Warrants”) to purchase 0.25 of a share of Common Stock, subject to adjustment (Note 10). Proceeds and expenses from the sale of the Series A Preferred Units were allocated to the Series A Preferred Stock and Series A Preferred Warrants using their relative fair values on the date of issuance.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2020, the Company has been conducting a continuous public offering of Series A Preferred Stock and Series</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> D preferred stock, par value $0.001 per share (the “Series D Preferred Stock”), with an initial stated value of $25.00 per share, subject to adjustment (the “Series D Preferred Stock Stated Value”). The selling price of the Series A Preferred Stock in the offering has been, and is expected to continue to be, $25.00 per share and the selling price of the Series D Preferred Stock was $25.00 per share for all sales that occurred from the beginning of the offering to and including June 28, 2020 and is expected to be, and since June 29, 2020, has been, $24.50 per share through the end of the life of the offering.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company conducted a rights offering (the “Rights Offering”) pursuant to which the Company issued an aggregate of 8,521,589 shares of Common Stock at a subscription price of $9.25 per share for aggregate gross proceeds of $78.8 million before issuance costs of $1.9 million. </span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has qualified and intends to continue to qualify as a REIT, as defined in the Internal Revenue Code of 1986, as amended.</span></div>
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q4 cmct Preferred Stock Including Temporary Equity Shares Authorized
PreferredStockIncludingTemporaryEquitySharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.003
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.003
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 cmct Loan And Leases Receivable Nonaccrual Loan And Lease Status Past Due Period
LoanAndLeasesReceivableNonaccrualLoanAndLeaseStatusPastDuePeriod
P60D
CY2020Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
-7800000 USD
CY2021 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2021Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
-9600000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
Loan Loss Reserves—On a quarterly basis, and more frequently if indicators exist, the Company evaluates the collectability of its loans receivable. The Company’s evaluation of collectability involves significant judgment, estimates, and a review of the ability of the borrower to make principal and interest payments, the underlying collateral and the borrowers’ business models and future operations. For the years ended December 31, 2021 and 2020, the Company recorded net impairment losses of $19,000 and a net recovery of $16,000, respectively, on its loans receivable. There were no material loans receivable subject to credit risk which were considered to be impaired as of December 31, 2021 or 2020. The Company considers a loan to be impaired when the Company does not expect to collect all of the contractual interest and principal payments as scheduled in the loan agreements. The Company also establishes a general loan loss reserve when available information indicates that it is probable a loss has occurred based on the carrying value of the portfolio and the amount of the loss can be reasonably estimated. Significant judgment is required in determining the general loan loss reserve, including estimates of the likelihood of default and the estimated fair value of the collateral. The general loan loss reserve includes those loans, which may have negative characteristics which have not yet become known to the Company. In addition to the reserves established on loans not considered impaired that have been evaluated under a specific evaluation, the Company establishes the general loan loss reserve using a consistent methodology to determine a loss percentage to be applied to loan balances. These loss percentages are based on many factors, primarily cumulative and recent loss history and general economic conditions.
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
19000 USD
CY2020 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-16000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
943000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
885000 USD
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
20870000 USD
CY2020Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
20470000 USD
CY2021Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
8971000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
7742000 USD
CY2021Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
8453000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
8950000 USD
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6281000 USD
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6046000 USD
CY2021Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
491000 USD
CY2020Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
490000 USD
CY2021Q4 cmct Deferred Rent Receivable And Charges Net
DeferredRentReceivableAndChargesNet
36095000 USD
CY2020Q4 cmct Deferred Rent Receivable And Charges Net
DeferredRentReceivableAndChargesNet
35956000 USD
CY2021Q4 us-gaap Incentive To Lessee
IncentiveToLessee
4000000 USD
CY2020Q4 us-gaap Incentive To Lessee
IncentiveToLessee
4000000 USD
CY2021Q4 cmct Incentive To Lessee Accumulated Amortization
IncentiveToLesseeAccumulatedAmortization
2700000 USD
CY2020Q4 cmct Incentive To Lessee Accumulated Amortization
IncentiveToLesseeAccumulatedAmortization
2400000 USD
CY2021 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
45773000 USD
CY2020 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
50245000 USD
CY2021 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
7065000 USD
CY2020 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
4578000 USD
CY2021 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
52838000 USD
CY2020 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
54823000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
579000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1900000 USD
CY2021 cmct Tenant Reimbursements Excluding Lease Agreements
TenantReimbursementsExcludingLeaseAgreements
0 USD
CY2020 cmct Tenant Reimbursements Excluding Lease Agreements
TenantReimbursementsExcludingLeaseAgreements
0 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases such estimates on historical experience, information available at the time, and assumptions the Company believes to be reasonable under the circumstances and at such time, including the impact of extraordinary events such as COVID-19. Actual results could differ from those estimates.</span>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Financial instruments that subject us to credit risk consist primarily of cash and cash equivalents and interest rate swap agreements. The Company has its cash and cash equivalents on deposit with what it believes to be high-quality financial institutions. Accounts at each institution are insured by the Federal Deposit Insurance Corporation up to $250,000. Management routinely assesses the financial strength of its tenants and, as a consequence, believes that its accounts receivable credit risk exposure is limited.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s revenues are earned from properties located in California. The Company is subject to risks incidental to the ownership and operation of commercial real estate. These include, among others, the risks normally associated with changes in the general economic climate in the communities in which the Company operates, trends in the real estate industry, changes in tax laws, interest rate levels, availability of financing, and the potential liability under environmental and other laws.</span></div>
CY2021 cmct Number Of Types Of Commercial Real Estate Properties
NumberOfTypesOfCommercialRealEstateProperties
2 property
CY2020 cmct Number Of Types Of Commercial Real Estate Properties
NumberOfTypesOfCommercialRealEstateProperties
2 property
CY2021Q4 us-gaap Land
Land
141236000 USD
CY2020Q4 us-gaap Land
Land
139397000 USD
CY2021Q4 us-gaap Land Improvements
LandImprovements
2644000 USD
CY2020Q4 us-gaap Land Improvements
LandImprovements
2611000 USD
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
454431000 USD
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
450741000 USD
CY2021Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4398000 USD
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4969000 USD
CY2021Q4 us-gaap Tenant Improvements
TenantImprovements
29733000 USD
CY2020Q4 us-gaap Tenant Improvements
TenantImprovements
31414000 USD
CY2021Q4 us-gaap Development In Process
DevelopmentInProcess
10260000 USD
CY2020Q4 us-gaap Development In Process
DevelopmentInProcess
8073000 USD
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
642702000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
637205000 USD
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
144718000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
131165000 USD
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
497984000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
506040000 USD
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
16900000 USD
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
17700000 USD
CY2021 cmct Number Of Properties Sold
NumberOfPropertiesSold
0 property
CY2020 cmct Number Of Properties Sold
NumberOfPropertiesSold
0 property
CY2021Q4 cmct Business Combination Recognized Identifiable Asset Acquired And Liability Assumed Below Market Lease
BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedBelowMarketLease
0 USD
CY2020Q4 cmct Business Combination Recognized Identifiable Asset Acquired And Liability Assumed Below Market Lease
BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedBelowMarketLease
5000 USD
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
2933000 USD
CY2020Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
6130000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
73260000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
83136000 USD
CY2021Q4 cmct Financing Receivables Deferred Capitalized Costs Net
FinancingReceivablesDeferredCapitalizedCostsNet
1226000 USD
CY2020Q4 cmct Financing Receivables Deferred Capitalized Costs Net
FinancingReceivablesDeferredCapitalizedCostsNet
884000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
943000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
885000 USD
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
73543000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
83135000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5251000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6313000 USD
CY2021 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
350000 USD
CY2020 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
700000 USD
CY2020Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
324313000 USD
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
35396000 USD
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
159696000 USD
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1132000 USD
CY2021Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
201145000 USD
CY2021Q4 cmct Line Of Credit Facility Accrued Interest And Unused Commitment Fee Payable
LineOfCreditFacilityAccruedInterestAndUnusedCommitmentFeePayable
467000 USD
CY2020Q4 cmct Line Of Credit Facility Accrued Interest And Unused Commitment Fee Payable
LineOfCreditFacilityAccruedInterestAndUnusedCommitmentFeePayable
564000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
62826000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1989000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2015000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2118000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
97978000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
36615000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
203541000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19979000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33467000 USD
CY2021 cmct Dilutive Securities Effect On Basic Earnings Per Share Redeemable Preferred Stock Dividends
DilutiveSecuritiesEffectOnBasicEarningsPerShareRedeemablePreferredStockDividends
0 USD
CY2020 cmct Dilutive Securities Effect On Basic Earnings Per Share Redeemable Preferred Stock Dividends
DilutiveSecuritiesEffectOnBasicEarningsPerShareRedeemablePreferredStockDividends
-1000 USD
CY2021 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-19979000 USD
CY2020 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-33468000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19187000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14748000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19187000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14748000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
190300000 USD
CY2021 cmct Preferred Stock And Warrants Offering Costs Issuance Specific Offering Costs
PreferredStockAndWarrantsOfferingCostsIssuanceSpecificOfferingCosts
15900000 USD
CY2021 cmct Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs
PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts
8000000 USD
CY2021Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7010799 USD
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
4541000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
6706000 USD
CY2021Q4 cmct Outstanding Loan Commitments And Approvals To Fund Loans
OutstandingLoanCommitmentsAndApprovalsToFundLoans
32600000 USD
CY2021Q4 cmct Tenant Improvements Obligations
TenantImprovementsObligations
8100000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
44521000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
42101000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
40059000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
24022000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
17246000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
32937000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
200886000 USD
CY2020Q4 cmct Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
0 USD
CY2021Q4 cmct Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
0 USD
CY2020 cmct Number Of Types Of Commercial Real Estate Properties
NumberOfTypesOfCommercialRealEstateProperties
2 property
CY2021 cmct Number Of Types Of Commercial Real Estate Properties
NumberOfTypesOfCommercialRealEstateProperties
2 property
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
143000 USD
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20112000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21406000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-281000 USD
CY2021 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2021 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2141000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15737000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2992000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-722000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-851000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-15015000 USD
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000 USD
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-850000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-15016000 USD
CY2021Q4 us-gaap Assets
Assets
660866000 USD
CY2020Q4 us-gaap Assets
Assets
685617000 USD
CY2021 cmct Capital Expenditures
CapitalExpenditures
5907000 USD
CY2020 cmct Capital Expenditures
CapitalExpenditures
9335000 USD
CY2021 cmct Disposal Group Including Discontinued Operation New Mortgage Loans
DisposalGroupIncludingDiscontinuedOperationNewMortgageLoans
133290000 USD
CY2020 cmct Disposal Group Including Discontinued Operation New Mortgage Loans
DisposalGroupIncludingDiscontinuedOperationNewMortgageLoans
53524000 USD
CY2021 cmct Capital Expenditures And Disposal Group Originations Cost
CapitalExpendituresAndDisposalGroupOriginationsCost
139197000 USD
CY2020 cmct Capital Expenditures And Disposal Group Originations Cost
CapitalExpendituresAndDisposalGroupOriginationsCost
62859000 USD
CY2021Q4 srt Real Estate And Accumulated Depreciation Amount Of Encumbrances
RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
97100000 USD
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Land
RealEstateAndAccumulatedDepreciationInitialCostOfLand
141236000 USD
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
450876000 USD
CY2021Q4 cmct Sec Schedule Iii Real Estate And Accumulated Depreciation Net Costs Capitalized Subsequent To Acquisition Or Writeoffs Buildings And Improvements
SecScheduleIiiRealEstateAndAccumulatedDepreciationNetCostsCapitalizedSubsequentToAcquisitionOrWriteoffsBuildingsAndImprovements
50590000 USD
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Carrying Amount Of Land
RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
141236000 USD
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
501466000 USD
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
642702000 USD
CY2021Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
144718000 USD
CY2021Q4 srt Real Estate Federal Income Tax Basis
RealEstateFederalIncomeTaxBasis
695100000 USD
CY2020Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
637205000 USD
CY2019Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
629262000 USD
CY2021 us-gaap Real Estate Improvements
RealEstateImprovements
5907000 USD
CY2020 us-gaap Real Estate Improvements
RealEstateImprovements
9335000 USD
CY2021 cmct Sec Schedule Iii Real Estate Acquisitions
SecScheduleIiiRealEstateAcquisitions
2933000 USD
CY2020 cmct Sec Schedule Iii Real Estate Acquisitions
SecScheduleIiiRealEstateAcquisitions
5709000 USD
CY2021 cmct Sec Schedule1228 Real Estate Companies Investment In Real Estate Assets Held For Sale
SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAssetsHeldForSale
0 USD
CY2020 cmct Sec Schedule1228 Real Estate Companies Investment In Real Estate Assets Held For Sale
SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAssetsHeldForSale
0 USD
CY2021 us-gaap Real Estate Cost Of Real Estate Sold
RealEstateCostOfRealEstateSold
0 USD
CY2020 us-gaap Real Estate Cost Of Real Estate Sold
RealEstateCostOfRealEstateSold
0 USD
CY2021 us-gaap Sec Schedule Iii Real Estate Writedown Or Reserve Amount
SECScheduleIIIRealEstateWritedownOrReserveAmount
0 USD
CY2020 us-gaap Sec Schedule Iii Real Estate Writedown Or Reserve Amount
SECScheduleIIIRealEstateWritedownOrReserveAmount
0 USD
CY2021 cmct Sec Schedule Iii Real Estate Retirements
SECScheduleIIIRealEstateRetirements
3343000 USD
CY2020 cmct Sec Schedule Iii Real Estate Retirements
SECScheduleIIIRealEstateRetirements
7101000 USD
CY2021Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
642702000 USD
CY2020Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
637205000 USD
CY2020Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
131165000 USD
CY2019Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
120555000 USD
CY2021 us-gaap Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense
SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
16896000 USD
CY2020 us-gaap Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense
SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
17711000 USD
CY2021 cmct Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Assets Held For Sale
SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationAssetsHeldForSale
0 USD
CY2020 cmct Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Assets Held For Sale
SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationAssetsHeldForSale
0 USD
CY2021 us-gaap Real Estate Accumulated Depreciation Real Estate Sold
RealEstateAccumulatedDepreciationRealEstateSold
0 USD
CY2020 us-gaap Real Estate Accumulated Depreciation Real Estate Sold
RealEstateAccumulatedDepreciationRealEstateSold
0 USD
CY2021 cmct Sec Schedule Iii Real Estate Accumulated Depreciation Retirements
SecScheduleIiiRealEstateAccumulatedDepreciationRetirements
3343000 USD
CY2020 cmct Sec Schedule Iii Real Estate Accumulated Depreciation Retirements
SecScheduleIiiRealEstateAccumulatedDepreciationRetirements
7101000 USD
CY2021Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
144718000 USD
CY2020Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
131165000 USD
CY2020Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
83135000 USD
CY2019Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
68079000 USD
CY2021 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
133290000 USD
CY2020 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
53524000 USD
CY2021 us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
2559000 USD
CY2020 us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
382000 USD
CY2021 cmct Accretion Of Loan Fees And Discounts
AccretionOfLoanFeesAndDiscounts
1424000 USD
CY2020 cmct Accretion Of Loan Fees And Discounts
AccretionOfLoanFeesAndDiscounts
933000 USD
CY2021 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
32370000 USD
CY2020 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
11580000 USD
CY2021 us-gaap Mortgage Loans On Real Estate Foreclosures
MortgageLoansOnRealEstateForeclosures
0 USD
CY2020 us-gaap Mortgage Loans On Real Estate Foreclosures
MortgageLoansOnRealEstateForeclosures
174000 USD
CY2021 us-gaap Mortgage Loans On Real Estate Cost Of Mortgages Sold
MortgageLoansOnRealEstateCostOfMortgagesSold
114437000 USD
CY2020 us-gaap Mortgage Loans On Real Estate Cost Of Mortgages Sold
MortgageLoansOnRealEstateCostOfMortgagesSold
27609000 USD
CY2021 cmct Mortgage Loans On Real Estate Other Bad Debt Expense Net Of Recoveries
MortgageLoansOnRealEstateOtherBadDebtExpenseNetOfRecoveries
58000 USD
CY2020 cmct Mortgage Loans On Real Estate Other Bad Debt Expense Net Of Recoveries
MortgageLoansOnRealEstateOtherBadDebtExpenseNetOfRecoveries
420000 USD
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
73543000 USD
CY2020Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
83135000 USD

Files In Submission

Name View Source Status
0000908311-22-000036-index-headers.html Edgar Link pending
0000908311-22-000036-index.html Edgar Link pending
0000908311-22-000036.txt Edgar Link pending
0000908311-22-000036-xbrl.zip Edgar Link pending
cmct-20211231.htm Edgar Link pending
cmct-20211231.xsd Edgar Link pending
cmct-20211231_cal.xml Edgar Link unprocessable
cmct-20211231_def.xml Edgar Link unprocessable
cmct-20211231_htm.xml Edgar Link completed
cmct-20211231_lab.xml Edgar Link unprocessable
cmct-20211231_pre.xml Edgar Link unprocessable
cmct-xbylaws2022.htm Edgar Link pending
exhibit211202110-k.htm Edgar Link pending
exhibit231202110-k.htm Edgar Link pending
exhibit311202110-k.htm Edgar Link pending
exhibit312202110-k.htm Edgar Link pending
exhibit321202110-k.htm Edgar Link pending
exhibit322202110-k.htm Edgar Link pending
exhibit41202110-k.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending